Solta Medical, Inc.
25881 Industrial Boulevard
Hayward
California
94545
United States
Tel: 877-782-2286
Fax: 510-782-2287
Website: http://www.solta.com/
Email: info@solta.com
140 articles about Solta Medical, Inc.
-
CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
1/18/2024
Bausch Health Companies Inc. and Solta Medical, a global leader in the medical aesthetics market, announced the approval of Thermage® FLX and the TR-4 Return Pad by China's National Medical Products Administration.
-
Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
1/18/2024
Bausch Health Companies Inc. and Solta Medical, a global leader in the medical aesthetics market, announced the approval of Thermage® FLX and the TR-4 Return Pad by China's National Medical Products Administration.
-
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
8/13/2018
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that John (Jack) Glenn has been appointed to the position of Chief Financial Officer.
-
Solta Medical Nabs FDA Nod for Thermage FLX System, Newest Generation Skin Smoothing Technology
10/4/2017
-
Solta Medical, Inc. Release: Clear + Brilliant pélo, The Game Changer In Laser Hair Removal
6/7/2016
-
Solta Medical, Inc. Launches Clear + Brilliant pelo: A New And Innovative Linear-Scanning Technology For Laser Hair Removal
9/10/2015
-
Valeant Pharmaceuticals International Completes Acquisition Of Solta Medical, Inc.
1/24/2014
-
Valeant Pharmaceuticals International Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
1/15/2014
-
NovaBay Pharmaceuticals, Inc. Appoints Mark M. Sieczkarek, Solta Medical, Inc. Chairman And CEO And Dr. Massimo Radaelli, Noventia Pharma CEO To Its Board Of Directors
1/9/2014
-
Acquisition of Solta Medical, Inc. By Valeant Pharmaceuticals International May Not Be In Shareholders' Best Interests
12/17/2013
-
Valeant Pharmaceuticals International Takes Over Solta Medical, Inc. For $250 Million Cash
12/16/2013
-
Solta Medical, Inc. To Present At The 25th Annual Piper Jaffray Health Conference
11/21/2013
-
Solta Medical, Inc. Sets Up $60 Million Credit Deal
11/21/2013
-
Solta Medical, Inc. Secures $40 Million Financing
11/18/2013
-
Solta Medical, Inc. To Reduce Workforce, Explore Sale In Restructuring
11/12/2013
-
Solta Medical, Inc. Reports Third Quarter 2013 Results And Actions Implemented To Improve Shareholder Returns
11/12/2013
-
Solta Medical, Inc. To Present At CanaccordGenuity Medical Technology & Diagnostics Forum
11/11/2013
-
Solta Medical, Inc. to Report Third Quarter 2013 Results and Host Conference Call on November 11, 2013
10/29/2013
-
Solta Medical, Inc. Seeks Help to Lead CEO Search
9/3/2013
-
Solta Medical, Inc. to Present at the 33rd Annual Canaccord Growth Conference
8/9/2013